A major outlet publishes an investigative piece on the Rogan-linked FDA nominee's psychedelic-policy conflicts within 8 weeks.

A major news organization is expected to publish a deep investigation into a person nominated to lead the FDA (the US drug regulator) who has connections to Joe Rogan and psychedelic advocacy groups. The story would focus on whether those ties create a conflict of interest — meaning the nominee might push drug policy in ways that benefit people they're personally connected to rather than acting independently. This matters because the FDA controls which drugs get approved and how safely they're rolled out.

The nominee-Rogan-advocacy nexus is irresistible copy with clear conflict angles. Documents and sources are already circulating; this is a certainty absent a withdrawal.